SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThe Mission Group Regulatory News (TMG)

Share Price Information for The Mission Group (TMG)

Share Price is delayed by 15 minutes
Get Live Data
17.50    0.00 (0.00%)
Bid:
17.00
Ask:
18.00
Spread: 1.00 (5.882%)
Market Cap: £15.85m
TMG Live PriceLast checked at - London Stock Exchange

Intraday The Mission Group Share Chart

Close Period update

2 Mar 2010 07:00

RNS Number : 8920H
The Mission Marketing Group PLC
02 March 2010
 



 

 

The Mission Marketing Group plc 

 

Close Period update

 

2 March 2010

 

The Mission Marketing Group plc ('themission®`, AIM: TMMG), the national marketing communications and advertising group, today issued the following close period update for the year ended 31 December 2009 ahead of its preliminary results announcement in April 2010.

 

As reported previously, the media sector experienced extremely difficult trading conditions during the first half of the year and this continued into the second half. Against this background themission nevertheless anticipated that incomes in the second half would hold up in line with the first six months and this has been achieved. Group agencies have maintained a strong new business performance with some signs of the beginnings of recovery, as previously indicated, in the Property and Financial Services sectors. Recent wins include Redrow, Canon, Avanade, M&S Money, Skills Development Scotland, Legal & General Investments, Oasis Dental, Virgin Media, Manchester Airports Group, Blockbuster, Holland and Barrett and Sensodyne.

 

Margins remained under pressure, due to ongoing client cost constraints and the need to hire additional staff as a result of increased activity in some client segments during the final quarter. As a result, profitability improved to a lesser degree than anticipated at the time of the Interim Results in September and operating profit for the full year will be somewhat below previous expectations. Our lower structural cost base meant that margins were maintained at the upper end of sector norms, at 15%.

 

Overall, trading for the current year is in line with expectations. However, taking into account the effects of the market downturn and the ongoing uncertainty in the broader UK economy, the Board continues to adopt a conservative outlook for the year. Further steps are being taken to structure the Group and to strengthen the balance sheet for 2010 and beyond and our annual impairment review is expected to trim the carrying value of goodwill by up to 10%.

 

Iain Ferguson, Chief Executive Officer, commented:

 

"In light of the continuing difficult trading environment, we believe that the Group's performance, the effective work delivered for our clients, the strength in new business and the momentum in our agencies are all encouraging. We are continuing to take initiatives to ensure the Group is well placed to benefit from a cyclical recovery."

 

Iain Ferguson, Chief Executive

The Mission Marketing Group plc

 

020 7758 3525

Tim Alderson, Chief Financial Officer

The Mission Marketing Group plc

 

020 7758 3520

Charles Palmer/Nicola Biles

Financial Dynamics

 

020 7831 3113

Mark Percy

Seymour Pierce Limited

020 7107 8000

 

www.themission.co.uk 

 

themission® is a national marketing communications and advertising group with 11 offices across the UK. The Group specialises in providing national and international clients with award winning marketing, advertising and business communications.

 

Group members include April-Six, Bray Leino, Big Communications, Fuse Digital, thinkBDW, Story UK and RLA. themission® employs over 550 staff nationally and is listed on AIM (TMMG).

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBRGDXGXGBGGB
Date   Source Headline
18th Aug 202210:30 amRNSEBT Share Dealing
17th Aug 20228:45 amRNSEBT Share Dealing
15th Aug 20222:29 pmRNSEBT Share Dealing
12th Aug 20227:00 amRNSEBT Share Dealing
10th Aug 20229:00 amRNSEBT Share Dealing
8th Aug 20228:51 amRNSEBT Share Dealing
5th Aug 20229:36 amRNSEBT Share Dealing
3rd Aug 20227:00 amRNSEBT Share Dealing
25th Jul 20223:47 pmRNSEBT Share Dealing
20th Jul 20228:22 amRNSEBT Share Dealing
19th Jul 20227:00 amRNSEBT Share Purchase
15th Jul 202210:22 amRNSEBT Share Purchase
14th Jul 20229:34 amRNSEBT Share Dealing
13th Jul 20227:00 amRNSTrading Update
8th Jul 20229:02 amRNSEBT Share Dealing
5th Jul 20223:44 pmRNSEBT Share Dealing
30th Jun 20228:55 amRNSEBT Share Dealing
29th Jun 202211:54 amRNSEBT Share Dealing
21st Jun 20222:35 pmRNSResult of AGM
17th Jun 20227:00 amRNSEBT Share Dealing
16th Jun 20227:00 amRNSEBT Share Dealing
15th Jun 20227:00 amRNSEBT Share Dealing
14th Jun 20227:00 amRNSEBT Share Dealing
13th Jun 20227:00 amRNSEBT Share Dealing
10th Jun 20227:00 amRNSEBT Share Dealing
9th Jun 20227:00 amRNSEBT Share Dealing
1st Jun 20228:46 amRNSEBT Share Dealing
31st May 20227:00 amRNSEBT Share Dealing
24th May 202210:48 amRNSEBT Share Dealing
23rd May 20227:00 amRNSEBT Share Dealing
20th May 20227:00 amRNSEBT Share Dealing
19th May 20227:00 amRNSEBT Share Dealing
18th May 20227:00 amRNSEBT Share Dealing
17th May 20227:00 amRNSEBT Share Dealing
16th May 20227:00 amRNSEBT Share Dealing
12th May 20222:36 pmRNSEBT Share Dealing
20th Apr 20229:04 amRNSDirector Dealing
30th Mar 20227:00 amRNSDividend Timetable
29th Mar 20227:00 amRNSFINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2021
28th Feb 20227:00 amRNSACQUISITION OF LIVITY
19th Jan 20227:00 amRNSTrading Update
11th Jan 20227:00 amRNSDirector/PDMR Shareholding
10th Jan 20221:54 pmRNSHolding(s) in Company
5th Jan 202210:07 amRNSHolding(s) in Company
17th Dec 20217:00 amRNSDirectorate Change
29th Nov 202110:16 amRNSHolding(s) in Company
25th Oct 20214:49 pmRNSHolding(s) in Company
20th Oct 20217:00 amRNSAcquisition of Soul and Trading Update
24th Sep 20217:30 amRNSHolding(s) in Company
23rd Sep 20216:10 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.